GlassScriptPhysician profile
Shashank Garg
NPI 1437447554
$6,449.34
in general payments reported to CMS, 2019-2025
18 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $375 · 2022: $551 · 2023: $2,668 · 2024: $2,147 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,475 · Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,474.72 |
| Food and Beverage | $2,048.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,752.11 | 2023-2024 | Resolution 360 Clip |
| Abbvie INC. | $795.50 | 2021-2025 | |
| Ovesco Endoscopy USA, INC. | $696.92 | 2024 | |
| Braintree Laboratories, INC. | $230.90 | 2021-2022 | |
| Fujifilm Healthcare Americas Corporation | $222.22 | 2025 | |
| Medtronic, INC. | $117.92 | 2025 | Nexpowder |
| Genzyme Corporation | $114.08 | 2025 | |
| Olympus America INC. | $101.78 | 2024-2025 | Hanarostent Esophagus Tts(Ccc), Single Use Repositionable Clip |
| Merit Medical Systems INC | $80.36 | 2025 | Esophageal Stent/Delivery System, Endomaxx Stent and Delivery System |
| Takeda Pharmaceuticals U.S.A., INC. | $77.55 | 2021-2023 | Entyvio |
| Merck Sharp & Dohme LLC | $72.34 | 2022-2023 | Dificid |
| Celgene Corporation | $39.92 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.14 | 2021-2023 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $30.25 | 2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $28.61 | 2025 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $26.71 | 2022 | |
| Nestle Healthcare Nutrition INC. | $18.94 | 2021 | |
| Amgen INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashank Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.